Home › Funds › GREAT POINT PARTNERS LLC › VERA
GREAT POINT PARTNERS LLC position in VERA
VERA THERAPEUTICS INC · Health Care
GREAT POINT PARTNERS LLC reported holding 600,836 shares of VERA (VERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$25.8M, representing 5.42% of its reported portfolio and ranking #4 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed VERA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GREAT POINT PARTNERS LLC's VERA position evolved
GREAT POINT PARTNERS LLC first disclosed a stake in VERA in Q1 2026 at 199,348 shares (US$8.0M). The position peaked in Q2 2026 at 600,836 shares, worth US$25.8M. Across 2 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 600,836 shares valued at US$25.8M — an increase of 401,488 shares quarter over quarter.. Notable position changes include a 201% increase in Q2 2026 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 199.35K | $8.02M | New |
| Q2 2026 | 600.84K | $25.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VERA and 13F data
VERA (VERA THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VERA
- Avoro Capital Advisors LLC 5.72M sh · $245.61M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $171.64M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.92M sh · $168.05M · Q2 2026
- Kynam Capital Management, LP 2.89M sh · $124.01M · Q2 2026
- Sofinnova Investments, Inc. 2.79M sh · $119.89M · Q2 2026
- Eversept Partners, LP 2.21M sh · $94.95M · Q2 2026
- Logos Global Management LP 2.20M sh · $94.40M · Q2 2026
- Integral Health Asset Management, LLC 1.75M sh · $75.09M · Q2 2026
- Bellevue Group AG 1.71M sh · $73.41M · Q2 2026
- BRAIDWELL LP 564.72K sh · $24.23M · Q2 2026
- Davern Capital Partners, LP 498.83K sh · $21.40M · Q2 2026
More on GREAT POINT PARTNERS LLC
FAQ
How long has GREAT POINT PARTNERS LLC held VERA?
GREAT POINT PARTNERS LLC has disclosed VERA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is GREAT POINT PARTNERS LLC's current position in VERA?
As of Q2 2026, GREAT POINT PARTNERS LLC holds 600.84K shares of VERA (VERA THERAPEUTICS INC), valued at $25.78M, representing 5.42% of its reported portfolio and ranking #4.
Has GREAT POINT PARTNERS LLC been buying or selling VERA?
In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC increased its position in VERA. The position peaked in Q2 2026 at 600.84K shares.
Which other funds hold VERA?
Other major institutional holders of VERA include Avoro Capital Advisors LLC, Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.